You are here

AstraZeneca

AstraZeneca drops Amgen-partnered solid tumor drug

Fierce Biotech

Fri, 05/18/18 - 09:37 pm

AstraZeneca pay report rejected by 35 percent of shareholders

Yahoo/Reuters

Fri, 05/18/18 - 09:30 pm

Another disappointing quarter for AstraZeneca, shares drop 2%

GoinPharma

Fri, 05/18/18 - 12:30 pm

AstraZeneca’s 1Q18 Earnings: Analysts' Estimates

Market Realist

Tue, 05/15/18 - 11:45 am

AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD

CP Wire

Fri, 05/11/18 - 10:03 am

AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD

Fri, 05/11/18 - 10:01 am

Luye Pharma Buys Rights to Seroquel in China and Other Territories for $538 Million

CP Wire

Mon, 05/7/18 - 05:26 pm

Luye Pharma Group

Luye Pharma Buys Rights to Seroquel in China and Other Territories for $538 Million

Mon, 05/7/18 - 05:22 pm

Luye Pharma Group

Immunotherapies, biosimilars to dominate next week of earnings

Biopharma Dive

Tue, 04/24/18 - 10:50 pm

Bristol-Myers Squibb

Vertex Pharmaceuticals

Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso

CP Wire

Thu, 04/19/18 - 12:30 am

cobas EGFR Mutation Test

non-small cell lung cancer

AstraZeneca Offers Outcomes-Based Pricing for Symbicort

Xtalks

Wed, 04/18/18 - 11:30 am

outcome-based pricing

AstraZeneca and Merck Present Updated Overall Survival Data for Lynparza in gBRCA-mutated HER2-Negative Metastatic Breast Cancer

CP Wire

Mon, 04/16/18 - 09:04 am

metastatic breast cancer

AstraZeneca and Merck Present Updated Overall Survival Data for Lynparza in gBRCA-mutated HER2-Negative Metastatic Breast Cancer

Mon, 04/16/18 - 01:21 am

HER-2 negative breast cancer

Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say

Biopharma Dive

Sat, 04/14/18 - 12:35 pm

Pfizer's Deal Potential Doesn't Stop at Bristol-Myers

Bloomberg

Fri, 04/13/18 - 08:52 am

Bristol-Myers Squibb

Ionis to get up to $300 mln from licensing deal with AstraZeneca

Yahoo/Reuters

Mon, 04/9/18 - 09:06 am

Ionis Pharmaceuticals

fatty liver disease

AstraZeneca taps Owlstone’s breath biopsy device to identify asthma, COPD biomarkers

Drug Delivery Business News

Mon, 04/9/18 - 09:04 am

Owlstone Medical

AstraZeneca’s once-weekly diabetes drug wins expanded FDA approval

Drug Delivery Business News

Tue, 04/3/18 - 10:52 pm

Compugen, AstraZeneca unit in cancer drug development deal

Yahoo/Reuters

Mon, 04/2/18 - 09:22 am

drug development

When Will They Learn? 4 Huge Biotech Blowups

Motley Fool

Thu, 03/29/18 - 09:24 pm

drug manufacturing

Cubist Pharmaceuticals

Pages